Petri S - Search Results

1

Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS.

Petri S, Körner S, Kiaei M. Petri S, et al. Neurol Res Int. 2012;2012:878030. doi: 10.1155/2012/878030. Epub 2012 Sep 20. Neurol Res Int. 2012. PMID: 23050144 Free PMC article.

2

Distribution of GABAA receptor mRNA in the motor cortex of ALS patients.

Petri S, Krampfl K, Hashemi F, Grothe C, Hori A, Dengler R, Bufler J. Petri S, et al. J Neuropathol Exp Neurol. 2003 Oct;62(10):1041-51. doi: 10.1093/jnen/62.10.1041. J Neuropathol Exp Neurol. 2003. PMID: 14575239

3

Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF. Kiaei M, et al. Among authors: petri s. J Neurochem. 2005 Apr;93(2):403-11. doi: 10.1111/j.1471-4159.2005.03024.x. J Neurochem. 2005. PMID: 15816863 Free article.

4

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.

Petri S, Kiaei M, Kipiani K, Chen J, Calingasan NY, Crow JP, Beal MF. Petri S, et al. Neurobiol Dis. 2006 Apr;22(1):40-9. doi: 10.1016/j.nbd.2005.09.013. Epub 2005 Nov 11. Neurobiol Dis. 2006. PMID: 16289867

5

Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice.

Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G. Damiano M, et al. Among authors: petri s. J Neurochem. 2006 Mar;96(5):1349-61. doi: 10.1111/j.1471-4159.2006.03619.x. J Neurochem. 2006. PMID: 16478527 Free article.

6

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Petri S, Kipiani K, Gardian G, Choi DK, Chen J, Calingasan NY, Schafer P, Muller GW, Stewart C, Hensley K, Beal MF. Kiaei M, et al. Among authors: petri s. J Neurosci. 2006 Mar 1;26(9):2467-73. doi: 10.1523/JNEUROSCI.5253-05.2006. J Neurosci. 2006. PMID: 16510725 Free PMC article.

7

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Petri S, et al. J Neurochem. 2006 Aug;98(4):1141-8. doi: 10.1111/j.1471-4159.2006.04018.x. J Neurochem. 2006. PMID: 16895581 Free article.

8

Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF. Kiaei M, et al. Among authors: petri s. Neurodegener Dis. 2005;2(5):246-54. doi: 10.1159/000090364. Neurodegener Dis. 2005. PMID: 16909005

9

Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.

Petri S, Kiaei M, Wille E, Calingasan NY, Flint Beal M. Petri S, et al. J Neurol Sci. 2006 Dec 21;251(1-2):44-9. doi: 10.1016/j.jns.2006.08.013. Epub 2006 Oct 17. J Neurol Sci. 2006. PMID: 17049562

10

The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.

Petri S, Calingasan NY, Alsaied OA, Wille E, Kiaei M, Friedman JE, Baranova O, Chavez JC, Beal MF. Petri S, et al. J Neurochem. 2007 Aug;102(3):991-1000. doi: 10.1111/j.1471-4159.2007.04604.x. J Neurochem. 2007. PMID: 17630988 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters